Curated News: NEJM

Filters close
Released: 16-Jan-2020 1:50 PM EST
Hackensack University Medical Center Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating Life-Threatening Seizures
Hackensack Meridian Health

Hackensack University Medical Center researchers in Emergency Medicine participated in a nationwide study published in the New England Journal of Medicine in November 2019 that concluded that three drugs are equally safe and effective in treating patients with life-threatening seizures called Status Epilepticus (SE). The new study, Established Status Epilepticus Treatment Trial (ESETT), examined three medications commonly administered in the emergency department to treat SE – levetiracetam, fosphenytoin, and valproate – in order to learn which is most effective in treating patients.

13-Jan-2020 5:50 PM EST
Global Team Enables Child With a Fatal Genetic Disease to Recover
Mount Sinai Health System

A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.

Released: 2-Jan-2020 7:05 AM EST
The Ultimate Telemedicine: UNC Expert Helps Treat Astronaut’s Blood Clot During NASA Mission
University of North Carolina School of Medicine

Moll was the only non-NASA physician NASA consulted when it was discovered that an astronaut aboard the ISS had a deep vein thrombosis (DVT) – or blood clot – in the jugular vein of their neck.

17-Dec-2019 2:20 PM EST
Caring for Transgender Persons: What Clinicians Should Know
Mount Sinai Health System

The New England Journal of Medicine review by Mount Sinai experts will serve as a major resource and guide for all physicians looking for best care strategies

Released: 11-Dec-2019 9:50 AM EST
New Study and Pilot Curriculum Trains Students to Provide Complex Care
Thomas Jefferson University

Thomas Jefferson University Hotspotting Program Addresses Hospital “Super Utilizers” Using Team-Based Model

27-Nov-2019 10:30 AM EST
Head-to-Head Comparison Finds Three Anti-Seizure Drugs Equally Effective for Severe Form of Epilepsy
Michigan Medicine - University of Michigan

A new clinical trial in the emergency department finds no difference in efficacy or adverse effects of three commonly used treatments for patients with refractory status epilepticus.

25-Nov-2019 11:45 AM EST
Better way to interpret blood tests to diagnose pulmonary embolism
McMaster University

A study led by Hamilton researchers has found a new way to interpret blood test results in patients who are investigated for blood clots in their lungs, a condition known as pulmonary embolism. This new approach applies to D-dimer blood tests, which are used by physicians to rule out the presence of a blood clot.

12-Nov-2019 10:00 AM EST
Secondary surgery does not improve overall survival for recurrent ovarian cancer patients
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.

Released: 31-Oct-2019 4:55 PM EDT
Three-drug combo improves lung function in most common genetic form of cystic fibrosis
UT Southwestern Medical Center

A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

Released: 23-Oct-2019 5:00 PM EDT
Mayo Clinic studies patient privacy in MRI research
Mayo Clinic

Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.

Released: 21-Oct-2019 10:05 AM EDT
Beta-blocker trial does not reduce risks for COPD patients
University of Alabama at Birmingham

Dransfield said their findings showed no evidence that beta-blockers were helpful in reducing the risk of exacerbations.

Released: 17-Oct-2019 7:00 AM EDT
New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn
Baylor Scott and White Health

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).

Released: 16-Oct-2019 8:05 PM EDT
Artificial pancreas system better controls blood glucose levels than current technology
Joslin Diabetes Center

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.The study showed that the system improved participants’ blood glucose control throughout the day and overnight.

16-Oct-2019 9:00 AM EDT
Artificial Pancreas System Better Controls Blood Glucose Levels than Current Technology
Mount Sinai Health System

Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes

Released: 3-Oct-2019 5:05 PM EDT
Según estudios, la lesión pulmonar asociada al uso del cigarrillo electrónico podría ser producto de los vapores tóxicos
Mayo Clinic

La investigación sobre la anatomía patológica de la lesión pulmonar asociada al uso del cigarrillo electrónico está en etapas iniciales, pero, de acuerdo con un estudio llevado adelante por Mayo Clinic que se publicó en el The New England Journal of Medicine, las lesiones pulmonares por uso del cigarrillo electrónico posiblemente son producto de la intoxicación directa o del daño en los tejidos provocado por los vapores químicos nocivos.

Released: 2-Oct-2019 5:05 PM EDT
Lesão pulmonar associada ao uso de cigarros eletrônicos pode ser causada por vapores químicos tóxicos, segundo estudo
Mayo Clinic

Um estudo liderado pela Mayo Clinic publicado no The New England Journal of Medicine descobriu que as lesões pulmonares causadas pelo uso de cigarros eletrônicos provavelmente são causadas por toxicidade direta ou dano tecidual causado por vapores químicos nocivos.

Released: 2-Oct-2019 5:05 PM EDT
Mit dem Vaping verbundene Lungenverletzungen können von giftigen chemischen Dämpfen verursacht werden, findet Studie heraus
Mayo Clinic

Eine von der Mayo Clinic geleitete Studie, die in The New England Journal of Medicine veröffentlicht wurde, hat ergeben, dass Lungenverletzungen durch Vaping höchstwahrscheinlich von der direkten Toxizität oder Gewebeverletzungen durch giftige chemische Dämpfe verursacht.

Released: 2-Oct-2019 5:05 PM EDT
D'après une étude, des lésions pulmonaires associées au vapotage pourraient être causées par des fumées chimiques toxiques
Mayo Clinic

Une étude menée par la Mayo Clinic et publiée dans The New England Journal of Medicine révèle que les lésions pulmonaires dues au vapotage sont très probablement causées par une toxicité directe ou des lésions tissulaires dues à des vapeurs chimiques nocives.

1-Oct-2019 3:00 PM EDT
Vaping-associated lung injury may be caused by toxic chemical fumes, study finds
Mayo Clinic

Research into the pathology of vaping-associated lung injury is in its early stages, but a Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.

Released: 2-Oct-2019 4:05 PM EDT
دراسة تكتشف أن إصابة الرئة المصاحبة لتدخين السجائر الإلكترونية قد تنتج عن أبخرة كيميائية
Mayo Clinic

لا يزال البحث في علم أمراض إصابات الرئة المصاحبة لتدخين السجائر الإلكترونية في مراحله الأولية، ولكن دراسة أجرتها Mayo Clinic ونشرتها في المجلة الطبية The New England Journal of Medicine وجدت أن إصابات الرئة بسبب تدخين السجائر الإلكترونية غالبًا ما تنتج عن التسمم المباشر أو تلف الأنسجة من جراء الأبخرة الكيميائية الضارة.



close
2.21377